Award of nanomatronix's DHA sbir sequential phase II medical r & d contract for "the ambit platform: an in vitro system for traumatic brain injury r & d", proposal no. H2-0710.

Ended Definitive Contract Awarded Last action

Contract number
W81XWH22C0118
Awardee
Awarding agency
Obligated
$1,099,994

Award facts

Opportunity
  • HQ003420RBDST Solicitation number
Contract value 100% obligated
$1,099,993.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Medical Command Department of the Army, Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fayetteville, AR 72701, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Defense health agency small business technology transfer sequential phase II medical research and development contract for project titled: the ambit platform:… $0
Supplemental Agreement for work within scope P00001 $0
Original award $1,099,994

About this award

This is a Small Business Innovation Research (SBIR) Sequential Phase II medical research and development contract awarded by the Defense Health Agency (DHA) to Nanomatronix LLC, a small business subchapter S corporation located in Fayetteville, Arkansas. The contract, valued at $1,099,993.64, is for the development of "The AMBIT Platform: An In Vitro System for Traumatic Brain Injury R&D." This project is focused on creating an in-vitro system to support research and development for traumatic brain injury. The contract has a total small business set-aside designation and is scheduled for completion by June 30, 2025. Nanomatronix LLC has a history of securing federal contracts, primarily through SBIR and Small Business Technology Transfer (STTR) programs, with various government agencies including the Air Force Research Laboratory, Department of the Army, and U.S. Army Medical Command.

Quick answers

Who was awarded contract W81XWH22C0118?

W81XWH22C0118 was awarded to Nanomatronix LLC by Defense Health Agency (Department of Defense) on September 22, 2022.

How much is contract W81XWH22C0118 worth?

The government has obligated $1,099,994 on W81XWH22C0118.

Which agency awarded contract W81XWH22C0118?

Defense Health Agency (Department of Defense) awarded W81XWH22C0118, with funding from Medical Command (Department of the Army).

Was contract W81XWH22C0118 competed?

The extent of competition for W81XWH22C0118 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award